• Family Conference 2023
  • DecNewsletter
  • First Legacy Guardian Peggy Davis


OUR MISSION

In our drive to find a cure for NBIA,
we provide support to families, educate the public and accelerate research with collaborators from around the world.


 

News

NBIAcure prepares to submit for FDA
approval of CoA-Z compound

 

Educational Resources

​Posters, flyers and
other educational handouts

 

Neuromuscular symptoms associated with all forms of NBIA share several descriptive terms. Dystonia describes involuntary muscle cramping that may force certain body parts into unusual, and sometimes painful, movements and positions. Choreoathetosis is characterized by involuntary, rapid, jerky movements (chorea) occurring in association with relatively slow, sinuous, writhing motions (athetosis).

In addition, there may be stiffness in the arms and legs because of continuous resistance to muscle relaxing (spasticity) and abnormal tightening of the muscles (muscular rigidity). Spasticiy and muscle rigidity usually begin in the legs and later develop in the arms. As affected individuals age, they may eventually lose control of voluntary movements. Muscle spasms combined with decreased bone mass can result in bone fractures (not caused by trauma or accident).

Dystonia affects the muscles in the mouth and throat, which may cause poor articulation and slurring (dysarthria) and difficulty swallowing (dysphagia). The progression of dystonia in these muscles can result in loss of speech as well as uncontrollable tongue-biting.

Specific forms of dystonia that may occur in association with NBIA include blepharospasm and torticollis. Blepharospasm is a condition in which the muscles of the eyelids do not function properly, resulting in excessive blinking and involuntary closing of the eyelids. Torticollis is a condition in which there are involuntary contractions of neck muscles resulting in abnormal movements and positions of the head and neck.

Most forms of NBIA involve eye disease. The most common problems are retinal degeneration and optic atrophy. The retina is a thin membrane that lines the back of the eyeball; it helps the eye perceive an image and send it into the brain. In NBIA, early signs of retinal degeneration may be poor night vision or tunnel vision. It can eventually cause significant loss of vision.

Optic atrophy affects the optic nerve, which sends messages between the retina and the brain. The optic nerve is like a cable with thousands of tiny electrical wires that each carry some visual information to the brain. When the nerve is damaged or breaks down, vision can become blurry, side vision or color vision may be abnormal, the pupil may not work properly, or there may be decreased lightness in one eye compared to the other. Eventually, optic atrophy can cause blindness.

Most forms of NBIA involve delays in development with motor skills (movement), and some, such as BPAN, the most common form of NBIA, also frequently have intellectual delays. Cognitive decline may also occur in some of the later-onset forms of NBIA. Although intellectual impairment has often been described as a part of the condition for all NBIA disorders in the past, it is unclear whether this is a true feature for some subtypes of NBIA disorders. Intellectual testing may be hampered by the movement disorder; therefore, newer methods of studying intelligence are necessary to determine if there are cognitive problems.

Seizures occur in some forms of NBIA and may need to be treated with anticonvulsants.

The diagnosis is usually suspected when brain MRI findings suggest abnormal iron accumulation in the basal ganglia. Although all of us have iron in this area, people with NBIA have extra iron made visible on MRI (magnetic resonance imaging) scans.  Certain views (T2-weighted images) show the iron as dark regions in the brain.  High brain iron is most often seen in the part of the basal ganglia called the globus pallidus and the substantia nigra.

The hallmark clinical manifestations of NBIA relate to the body’s muscle function and feature progressive dystonia (a movement disorder) and dysarthria (problems speaking), spasticity and parkinsonism, a condition marked by tremor, slowness, rigidity (stiff muscles) and poor balance.

Vision also may be affected. The most common conditions are degeneration of the retina and optic atrophy, the permanent loss of some or most of the fibers in the optic nerve. A general loss of brain cells and brain tissue also are frequently observed, conditions called cerebral atrophy and cerebellar atrophy.

Individuals with NBIA share an abnormality in the nerve cells that can only be detected by performing electron microscopy on nerve tissue obtained from a biopsy. Nerve cells have long extensions, called axons that transmit messages from one nerve cell to the next. In NBIA, some axons are swollen with collections of cellular debris or “junk” that should not be there. These swellings are called spheroids, spheroid bodies or axonal spheroids. In most forms of NBIA, spheroids are located only in the nerves of the brain and spinal cord. Therefore, they are usually not detected until after death, from an autopsy. In one form of NBIA, infantile neuroaxonal dystrophy (INAD), however, spheroids are also found in nerves throughout the body and a biopsy can be done on skin, muscle, or other tissue to look for them.  In a few cases of Mitochondrial-membrane Protein-Associated Neurodegeneration (MPAN), spheroids have also been found in peripheral nerves.

Clinical findings and genetic testing can establish the diagnosis of specific forms of NBIA.

* For more in depth information about diagnosing individual NBIA disorders, see their links under the NBIA Disorders heading at top of page.

Neurodegeneration with Brain Iron Accumulation (NBIA), is a group of rare, genetic neurological disorders, characterized by the progressive degeneration of the nervous system.

To date, 10 genes are associated with types of NBIA. The genes and the form of NBIA identified thus far are:

PANK2

Pantothenate Kinase-Associated Neurodegeneration

PKAN

PLA2G6

PLA2G6-Associated Neurodegeneration

PLAN

C19orf12

Mitochondrial-membrane Protein-Associated Neurodegeneration

MPAN

WDR45

Beta-propeller Protein-Associated Neurodegeneration

BPAN

COASY

COASY Protein-Associated Neurodegeneration

CoPAN

FA2H

Fatty-Acid Dyroxylase-associated Neurodegeneration

FAHN

CP

Aceruloplasminemia

 

ATP13A2

Kufor-Rakeb

 

FTL

Neuroferritinopathy

 

DCAF-17

Woodhouse-Sakati Syndrome

 

 

The common feature among all individuals with NBIA is iron accumulation in the brain along with a progressive movement disorder. This is especially seen in regions of the basal ganglia called the globus pallidus and the substantia nigra. The basal ganglia is a collection of structures deep within the base of the brain that assist in regulating movements. The exact relationship between iron accumulation and the symptoms of NBIA is not fully understood.

The frequency of NBIA in the general population is estimated between 1-3/1,000,000 individuals.

Affected individuals can plateau for long periods of time and then undergo intervals of rapid deterioration. Symptoms may vary greatly from case to case, partly because there are different genes causing NBIA. Also, different mutations within a gene could lead to a more or less severe presentation. The factors that influence disease severity and rate of progression are unknown.

The movement disorders result in clumsiness, difficulty controlling the body and speech problems. Dystonia, spasticity and visual disorders are common clinical signs.

Many individuals eventually lose the ability to walk, talk or chew food and become totally dependent on others for their care.

*  For more in depth information about all NBIA disorders, see the Overview of NBIA Disorders

** For more in depth information about individual NBIA disorders, see their links under the NBIA Disorders heading at top of page.

Partners

nbia alliance logo1NBIA Cure logoRare Disease Day PartnerTIRCON

Genetic Alliance logoNORDEURORDISGlobal Genes


Disclaimer    |     Privacy Policy    |     Financials    |     Contact Us

Give While You Shop!

Igive.com

G-CFB5FV5NLL